Raymond James analyst Brian MacArthur initiated coverage of Uranium Royalty (UROY) with an Outperform rating and C$4.50 price target The firm says Uranium is “unique” as the largest publicly traded uranium focused royalty company. It believes royalty companies like Uranium offer equity investors exposure to commodity prices while mitigating downside risk given limited exposure to operating and capital costs. At the same time, upside optionality exists through exploration and asset expansion potential, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UROY:
